Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Samsung Wins Over Netlist in U.S. Patent Battle

inews24 Views  

After disputes over memory semiconductor module patents
All five cases raised by Netlist invalidated

Samsung Electronics has won a patent invalidation lawsuit against American semiconductor company Netlist over memory semiconductor module patents.

A view of Samsung Electronics’ Seocho office building [Photo by Kwon Yong Sam]

According to industry sources, on the 4th, the U.S. Patent Trial and Appeal Board (PTAB) ruled in favor of Samsung Electronics in two patent invalidation lawsuits filed by the company on the 2nd (local time). With this, all five patents that Netlist claimed were infringed have been invalidated, including three that had already received invalidation rulings. As a result, all the bases for the payment ruling in the lawsuit that took place last year in the U.S. District Court for the Eastern District of Texas have disappeared.

Netlist, headquartered in Irvine, California, was founded in 2000 by Hong Chun Ki, a former LG Semiconductor executive. The lawsuit between Samsung Electronics and Netlist began in 2015 when Netlist claimed a breach of a joint development and licensing agreement signed by both companies.

In 2021, Netlist filed a lawsuit claiming that the memory technology used in Samsung Electronics’ cloud computing servers infringed on its patents. At the time, Netlist argued that its technology improved the efficiency of memory modules, enabling them to extract useful information from large amounts of data quickly, and that Samsung Electronics took the patented technology after collaborating on the project. On the other hand, Samsung Electronics countered that Netlist’s patent was invalid and that its technology operated differently from Netlist’s.

In response, a U.S. jury ruled in April last year that Samsung Electronics had infringed on five of Netlist’s patents. In August of the same year, the court accepted the jury’s verdict and ordered Samsung Electronics to pay Netlist $330 million in damages.

Unsatisfied with the ruling, Samsung Electronics requested an invalidation review of the five patents with the U.S. Patent Trial and Appeal Board. Three of them have already been invalidated, and the remaining two have also been invalidated. Thus, all of Samsung Electronics’ claims have been accepted in all cases.

As all the patents that Netlist presented as the basis for the lawsuit have been invalidated, industry analysis suggests that Samsung Electronics has gained the upper hand in the patent dispute between the two companies. However, there is a possibility that Netlist may appeal the invalidation decision. In that case, it will be finalized in the appellate court.

inews24
content@viewusglobal.com

Comments0

300

Comments0

[WORLD] Latest Stories

  • Porsche Taycan GTS Breaks Guinness Record with 10.9-Mile Ice Drift
  • Africa's MPOX Variant Clade 1b Reaches France: Health Officials Take Action
  • LA Wildfires’ Economic Toll Hits $50 Billion, Doubling Early Estimates
  • Real Reason Trump Wants Greenland and the Panama Canal: Geopolitical Dominance
  • Biden Targets China, Russia with New Semiconductor Export Limits
  • Wildfire Chaos in California: 150,000 Evacuated as Flames Spread

You May Also Like

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE&nbsp

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE&nbsp

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE&nbsp

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE&nbsp

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE&nbsp

Must-Reads

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE